Skip to main content

Alexion Pharmaceuticals



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.9%. By the end of trading, Alexion Pharmaceuticals rose $3.78 (4.3%) to $92.54 on heavy volume. Throughout the day, 5.6 million shares of Alexion Pharmaceuticals exchanged hands as compared to its average daily volume of 1.2 million shares. The stock ranged in a price between $91.80-$94.36 after having opened the day at $91.80 as compared to the previous trading day's close of $88.76. Other companies within the Health Care sector that increased today were:




), up 16.4%,




), up 10.3%,

Fonar Corporation



), up 9.9%, and

Scroll to Continue

TheStreet Recommends

CAS Medical Systems



), up 9.7%.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. Alexion Pharmaceuticals has a market cap of $15.75 billion and is part of the


industry. The company has a P/E ratio of 84.3, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 24.1% year to date as of the close of trading on Monday. Currently there are 16 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and four rate it a hold.

TheStreet Ratings rates Alexion Pharmaceuticals as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front,

Biosante Pharmaceuticals



), down 13%,




), down 12.9%,




), down 12.7%, and

Chelsea Therapeutics International



), down 12%, were all losers within the health care sector with

Thermo Fisher Scientific



) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care